Purchases and Sales Made in Q1 2024 in Maxcyte, Inc. (MXCT)
This table provides information about the institutional ownership of Maxcyte, Inc. (MXCT) during Q1 2024. The information is specifically focused on institutions that hold shares of MAXCYTE, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-79.2K- 58.61% |
$312K - $426K
|
55.9K
$276K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-112K- 1.52% |
$441K - $602K
|
7.23M
$35.7M
|
|
|
May 15, 2024
Q1 2024
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-116K- 8.41% |
$455K - $622K
|
1.26M
$6.22M
|
|
|
May 13, 2024
Q1 2024
|
Royce & Associates LP
|
SELL
|
- |
-246K- 75.12% |
$969K - $1.32M
|
81.4K
$402K
|
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-305K- 21.08% |
$1.2M - $1.64M
|
1.14M
$5.65M
|
|
|
May 15, 2024
Q1 2024
|
Grandeur Peak Global Advisors, LLC
Salt Lake City, UT |
SELL
|
- |
-406K- 61.83% |
$1.6M - $2.19M
|
251K
$1.24M
|
|
|
May 15, 2024
Q1 2024
|
Portolan Capital Management, LLC
Boston, MA |
SELL
|
- |
-1.04M- 37.55% |
$4.08M - $5.57M
|
1.72M
$8.51M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.12M- 24.14% |
$4.41M - $6.03M
|
3.52M
$17.4M
|
|
|
May 15, 2024
Q1 2024
|
Blue Water Life Science Advisors, LP
Larkspur, CA |
SELL
|
- |
-1.28M- 67.96% |
$5.05M - $6.89M
|
604K
$2.98M
|